Robert Roe explores the use of AI technology in healthcare and medicinal research
Robert Roe explores efforts to diversify the HPC processor market
Robert Roe looks at the role of integrators to deliver and support HPC systems
Robert Roe reports back from SC17 conference on high performance computing
Robert Roe reports from the SC17 conference keynote, detailing progress on the Square kilometre Array project
Robert Roe reports on the potentially far-reaching benefits of exascale computing for European research
Robert Roe finds that as cloud computing matures, it is attracting new users who are choosing to adopt it to supplement existing computing resources
Gemma Church explores applications at the forefront of HPC research
Adrian Giordani explores the methods used to accurately measure the performance of supercomputers
Robert Roe looks at advances in AI computing technology
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.
Cloud research tools provide a platform for new avenues of scientific research by providing fast access to bare-metal resources.
New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.
Tate Cantrell, CTO, Verne Global, comments on the cost of the AI computing revolution
European researchers are working on a new programming environment for exascale computing that aims to make using these systems more efficient and programmers more productive.
